101 related articles for article (PubMed ID: 22750438)
1. Chemical stability of phospholipid-stabilized supercooled smectic cholesteryl myristate nanoparticles.
Mengersen F; Bunjes H
Eur J Pharm Biopharm; 2012 Oct; 82(2):262-71. PubMed ID: 22750438
[TBL] [Abstract][Full Text] [Related]
2. Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.
Kuntsche J; Bunjes H
Eur J Pharm Biopharm; 2007 Nov; 67(3):612-20. PubMed ID: 17574399
[TBL] [Abstract][Full Text] [Related]
3. PEGylation of supercooled smectic cholesteryl myristate nanoparticles.
Mengersen F; Bunjes H
Eur J Pharm Biopharm; 2012 Jun; 81(2):409-17. PubMed ID: 22487056
[TBL] [Abstract][Full Text] [Related]
4. Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers.
Kuntsche J; Koch MH; Drechsler M; Bunjes H
Colloids Surf B Biointerfaces; 2005 Jul; 44(1):25-35. PubMed ID: 15990283
[TBL] [Abstract][Full Text] [Related]
5. Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles.
Kuntsche J; Koch MH; Steiniger F; Bunjes H
J Colloid Interface Sci; 2010 Oct; 350(1):229-39. PubMed ID: 20619846
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stability of dispersions prepared from purified marine phospholipid and the role of α-tocopherol.
Lu FS; Nielsen NS; Baron CP; Diehl BW; Jacobsen C
J Agric Food Chem; 2012 Dec; 60(50):12388-96. PubMed ID: 23190180
[TBL] [Abstract][Full Text] [Related]
7. Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.
Kuntsche J; Westesen K; Drechsler M; Koch MH; Bunjes H
Pharm Res; 2004 Oct; 21(10):1834-43. PubMed ID: 15553230
[TBL] [Abstract][Full Text] [Related]
8. Stability of the Metastable α-Polymorph in Solid Triglyceride Drug-Carrier Nanoparticles.
Joseph S; Rappolt M; Schoenitz M; Huzhalska V; Augustin W; Scholl S; Bunjes H
Langmuir; 2015 Jun; 31(24):6663-74. PubMed ID: 26030714
[TBL] [Abstract][Full Text] [Related]
9. Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity.
Kuntsche J; Koch MH; Fahr A; Bunjes H
Eur J Pharm Sci; 2009 Oct; 38(3):238-48. PubMed ID: 19664705
[TBL] [Abstract][Full Text] [Related]
10. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
11. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
[TBL] [Abstract][Full Text] [Related]
12. The physical state of lipid nanoparticles influences their effect on in vitro cell viability.
Petersen S; Steiniger F; Fischer D; Fahr A; Bunjes H
Eur J Pharm Biopharm; 2011 Sep; 79(1):150-61. PubMed ID: 21458564
[TBL] [Abstract][Full Text] [Related]
13. Formulation and shelf life stability of water-borne lecithin nanoparticles for potential application in dietary supplements field.
Edris AE
J Diet Suppl; 2012 Sep; 9(3):211-22. PubMed ID: 22891991
[TBL] [Abstract][Full Text] [Related]
14. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.
Bunjes H; Koch MH
J Control Release; 2005 Oct; 107(2):229-43. PubMed ID: 16023752
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles as vitamin matrix carriers in liquid food systems: On the role of high-pressure homogenisation, droplet size and adsorbed materials.
Shukat R; Relkin P
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):119-24. PubMed ID: 21524892
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
17. Effect of terminal heat sterilization on the stability of phospholipid-stabilized submicron emulsions.
Chaturvedi PR; Patel NM; Lodhi SA
Acta Pharm Nord; 1992; 4(1):51-5. PubMed ID: 1515053
[TBL] [Abstract][Full Text] [Related]
18. Storage stability and physical characteristics of tea-polyphenol-bearing nanoliposomes prepared with milk fat globule membrane phospholipids.
Gülseren I; Corredig M
J Agric Food Chem; 2013 Apr; 61(13):3242-51. PubMed ID: 23473473
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading.
Rosenblatt KM; Bunjes H
Eur J Pharm Biopharm; 2017 Aug; 117():49-59. PubMed ID: 28315731
[TBL] [Abstract][Full Text] [Related]
20. Parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism.
Kupetz E; Preu L; Kunick C; Bunjes H
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):511-20. PubMed ID: 23454203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
